HUT75734A - Expression of heterologous proteins in attenuated bacteria using the htra-promoters - Google Patents
Expression of heterologous proteins in attenuated bacteria using the htra-promotersInfo
- Publication number
- HUT75734A HUT75734A HU9602084A HU9602084A HUT75734A HU T75734 A HUT75734 A HU T75734A HU 9602084 A HU9602084 A HU 9602084A HU 9602084 A HU9602084 A HU 9602084A HU T75734 A HUT75734 A HU T75734A
- Authority
- HU
- Hungary
- Prior art keywords
- htra
- heterologous proteins
- promoters
- expression
- attenuated bacteria
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title abstract 3
- 230000002238 attenuated effect Effects 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 101150018266 degP gene Proteins 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 101150007310 htrA gene Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9401795A GB9401795D0 (en) | 1994-01-31 | 1994-01-31 | Vaccines |
| PCT/GB1995/000196 WO1995020665A1 (en) | 1994-01-31 | 1995-01-31 | Expression of heterologous proteins in attenuated bacteria using the htra-promoters |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9602084D0 HU9602084D0 (en) | 1996-09-30 |
| HUT75734A true HUT75734A (en) | 1997-05-28 |
| HU222982B1 HU222982B1 (hu) | 2004-01-28 |
Family
ID=10749598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9602084A HU222982B1 (hu) | 1994-01-31 | 1995-01-31 | Heterológ proteinek kifejezése attenuált baktériumokban htrA promoter alkalmazásával |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0742829B1 (hu) |
| JP (1) | JP3731004B2 (hu) |
| KR (1) | KR100392916B1 (hu) |
| AT (1) | ATE254178T1 (hu) |
| AU (1) | AU701384B2 (hu) |
| BR (1) | BR9506666A (hu) |
| CA (1) | CA2182315C (hu) |
| CZ (1) | CZ285867B6 (hu) |
| DE (1) | DE69532109T2 (hu) |
| DK (1) | DK0742829T3 (hu) |
| ES (1) | ES2210283T3 (hu) |
| FI (1) | FI119476B (hu) |
| GB (1) | GB9401795D0 (hu) |
| HU (1) | HU222982B1 (hu) |
| NZ (1) | NZ278930A (hu) |
| PL (1) | PL180091B1 (hu) |
| PT (1) | PT742829E (hu) |
| SK (1) | SK99696A3 (hu) |
| WO (1) | WO1995020665A1 (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9720033D0 (en) * | 1997-09-19 | 1997-11-19 | Medeva Plc | Hepatitis B virus polypeptides |
| US20020168771A1 (en) * | 2001-05-08 | 2002-11-14 | Gamerman Gary Eric | Vectors having replication, immunogenicity and/or pathogenicity under stress promoter regulation and use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68917126T2 (de) * | 1988-02-01 | 1995-02-02 | Praxis Biolog Inc | T-zellen-epitope als träger für einen konjugierten impfstoff. |
| CA2031468A1 (en) * | 1989-12-08 | 1991-06-09 | Mitchell S. Gross | Malaria vaccine |
| GB9007194D0 (en) * | 1990-03-30 | 1990-05-30 | Wellcome Found | Live vaccines |
| CA2099841C (en) * | 1991-03-05 | 2003-02-25 | Ian G. Charles | Expression of recombinant proteins in attenuated bacteria |
| KR950702635A (ko) * | 1992-07-31 | 1995-07-29 | 크리스틴 헬렌 수덴 | 감쇠 박테리아에서 재조합 융합 단백질의 발현(Expression of recombinant fusion proteins in attenuated bacteria) |
-
1994
- 1994-01-31 GB GB9401795A patent/GB9401795D0/en active Pending
-
1995
- 1995-01-31 WO PCT/GB1995/000196 patent/WO1995020665A1/en active IP Right Grant
- 1995-01-31 HU HU9602084A patent/HU222982B1/hu not_active IP Right Cessation
- 1995-01-31 EP EP95907080A patent/EP0742829B1/en not_active Expired - Lifetime
- 1995-01-31 DE DE69532109T patent/DE69532109T2/de not_active Expired - Lifetime
- 1995-01-31 SK SK996-96A patent/SK99696A3/sk unknown
- 1995-01-31 NZ NZ278930A patent/NZ278930A/en not_active IP Right Cessation
- 1995-01-31 PT PT95907080T patent/PT742829E/pt unknown
- 1995-01-31 AU AU15415/95A patent/AU701384B2/en not_active Ceased
- 1995-01-31 BR BR9506666A patent/BR9506666A/pt not_active Application Discontinuation
- 1995-01-31 AT AT95907080T patent/ATE254178T1/de active
- 1995-01-31 DK DK95907080T patent/DK0742829T3/da active
- 1995-01-31 KR KR1019960704245A patent/KR100392916B1/ko active IP Right Grant
- 1995-01-31 JP JP51995795A patent/JP3731004B2/ja not_active Expired - Lifetime
- 1995-01-31 CZ CZ962182A patent/CZ285867B6/cs not_active IP Right Cessation
- 1995-01-31 ES ES95907080T patent/ES2210283T3/es not_active Expired - Lifetime
- 1995-01-31 PL PL95315670A patent/PL180091B1/pl unknown
- 1995-01-31 CA CA002182315A patent/CA2182315C/en not_active Expired - Lifetime
-
1996
- 1996-07-30 FI FI963016A patent/FI119476B/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2210283T3 (es) | 2004-07-01 |
| HU222982B1 (hu) | 2004-01-28 |
| BR9506666A (pt) | 1997-09-09 |
| GB9401795D0 (en) | 1994-03-23 |
| FI119476B (fi) | 2008-11-28 |
| CZ218296A3 (en) | 1996-10-16 |
| NZ278930A (en) | 1998-07-28 |
| JPH09508276A (ja) | 1997-08-26 |
| DK0742829T3 (da) | 2004-03-22 |
| CZ285867B6 (cs) | 1999-11-17 |
| FI963016A0 (fi) | 1996-07-30 |
| AU1541595A (en) | 1995-08-15 |
| ATE254178T1 (de) | 2003-11-15 |
| PL180091B1 (pl) | 2000-12-29 |
| KR970700770A (ko) | 1997-02-12 |
| FI963016L (fi) | 1996-09-25 |
| CA2182315A1 (en) | 1995-08-03 |
| DE69532109T2 (de) | 2004-08-26 |
| EP0742829A1 (en) | 1996-11-20 |
| PL315670A1 (en) | 1996-11-25 |
| AU701384B2 (en) | 1999-01-28 |
| DE69532109D1 (de) | 2003-12-18 |
| HU9602084D0 (en) | 1996-09-30 |
| JP3731004B2 (ja) | 2006-01-05 |
| EP0742829B1 (en) | 2003-11-12 |
| KR100392916B1 (ko) | 2003-10-22 |
| PT742829E (pt) | 2004-04-30 |
| SK99696A3 (en) | 1997-01-08 |
| WO1995020665A1 (en) | 1995-08-03 |
| CA2182315C (en) | 2005-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7235794A (en) | Vaccine compositions | |
| HUT68261A (en) | Synthetic dna sequence having enhanced insecticidal activity in maize | |
| WO2001062794A3 (en) | 18607, a human calcium channel | |
| EP1308515A3 (en) | Porcine factor VIII | |
| MX9707071A (es) | Sistema de expresion de antigenos heterologos como proteinas de fusion. | |
| BG102983A (en) | Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application | |
| FI863891A0 (fi) | Menetelmiä sekropiinin ja muiden heterologisten polypeptidien tuottamiseksi bakteeri-isännässä araB-promoottoria käyttäen sekä menetelmissä käyttökelpoisia replikoituvia ekspressiovälineitä, geneettisiä muodostelmia ja bakteereja | |
| WO2002000722A3 (en) | Human calcium channels (48000; 52920) and uses thereof | |
| HU9801384D0 (en) | Clostridium perfringeus vaccine | |
| HU9602084D0 (en) | Expression of heterologous proteins in attenuated bacteria using the htra-promoters | |
| ZA978503B (en) | Vertebrate smoothened proteins | |
| DK0805204T3 (da) | Bitestikel - specifikt receptorprotein og anvendelse heraf | |
| IL86065A0 (en) | Bacillus thuringiensis p-2 toxin gene protein and related insecticide compositions | |
| ATE43139T1 (de) | Klonierungs- und expressionsvektoren fuer gammainterferon, transformierte bakterien und verfahren zur herstellung von gamma-interferon. | |
| AU2001253258A1 (en) | Human trp-like calcium channel protein-2 (tlcc-2) | |
| GB2295394A (en) | Vaccine Compositions | |
| ZA200007619B (en) | New peptide fragments for protein purification. | |
| IT8521507A0 (it) | Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni. | |
| GB9604518D0 (en) | Novel compounds | |
| WO2001077329A3 (en) | Human twik molecules and uses thereof | |
| WO2002026983A3 (en) | 56115, a novel human twik potassium channel and uses therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DGB9 | Succession in title of applicant |
Owner name: PEPTIDE THERAPEUTICS LIMITED, GB |
|
| HFG4 | Patent granted, date of granting |
Effective date: 20031127 |
|
| MM4A | Lapse of definitive patent protection due to non-payment of fees |